{
    "2018-07-18": [
        [
            {
                "time": "",
                "original_text": "融资客青睐22股，中国电建买入占比高达40.55％",
                "features": {
                    "keywords": [
                        "融资",
                        "中国电建",
                        "买入占比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "建筑"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：2018年抗癌药医保准入专项谈判将开展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "抗癌药",
                        "医保准入",
                        "专项谈判"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一心堂一心做事 借“入摩”之势打出组合拳",
                "features": {
                    "keywords": [
                        "一心堂",
                        "入摩",
                        "组合拳"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "申请豁免BE实验遭拒 白云山两药品未通过一致性评价",
                "features": {
                    "keywords": [
                        "白云山",
                        "BE实验",
                        "一致性评价",
                        "未通过"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}